Corporate ActionJun 3, 2026, 06:07 AM
BriaCell Therapeutics Raises $4.71M in Common Share Offering
AI Summary
BriaCell Therapeutics Corp. closed a best efforts offering on June 2, 2026, selling an aggregate of 1,449,300 common shares at an offering price of $3.25 per share. The offering resulted in gross proceeds of $4.71 million, which the company intends to use for working capital, general corporate purposes, and advancing business objectives. ThinkEquity LLC acted as the placement agent, receiving a 7.5% cash fee and warrants to purchase 72,465 common shares.
Key Highlights
- Closed best efforts offering of 1,449,300 common shares.
- Offering price set at $3.25 per common share.
- Generated gross proceeds of $4.71 million before deducting fees.
- Net proceeds to be used for working capital and general corporate purposes.
- Paid Placement Agent a cash fee of 7.5% of gross proceeds.
- Issued Placement Agent warrants to purchase 72,465 common shares.
- Placement Agent Warrants exercisable at $4.0625 per share, expiring in five years.
Price Impact
More from BCTX